Objectives: To describe the changing epidemiology of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in clinical samples in Denmark 2005-15 according to species and van type, and, furthermore, to investigate the genetic relatedness of the clinical E. faecium isolates from 2015.
Introduction
Enterococcus faecalis and Enterococcus faecium can cause community-acquired and nosocomial infections (e.g. urinary tract infections, intra-abdominal infections, bloodstream infections and endocarditis).
During recent decades, an increase in the occurrence of VRE has been observed in Europe with E. faecium being the most dominant species. 1, 2 Resistance to vancomycin can be encoded by several gene clusters (vanA/B/D/E/G/L/M/N). In Europe, the vanA and, to a lesser extent, vanB genotypes are most prevalent among clinical VRE isolates. 1, 3 The molecular epidemiology of E. faecium isolates has been investigated by several typing methods. For many years, the most commonly used method for the investigation of enterococcal clonality in relation to outbreak situations was PFGE analysis using SmaI as the restriction enzyme. 4 For investigation of population structures and global bacterial epidemiology, MLST has been the gold standard. MLST analysis has previously shown that the majority of the E. faecium isolates causing infections in patients and hospital outbreaks belong to a subpopulation previously called clonal complex 17 (CC17). 5 These are genetically very different from commensal E. faecium isolates from healthy humans and E. faecium isolates from farm animals. 6 In addition to MLST, WGS can be used for epidemiological studies and to compare population structures of E. faecium. Based on WGS data, the analysis of SNPs is now widely used for epidemiological studies. 4, 7, 8 Inferring the relationship between isolates based on SNPs generally uses variation within the conserved core genome of any given collection of WGS data. Thus, comparisons of isolates analysed at different times require re-analyses. This restricts proper nomenclature and reflects the obtained resolution of the dataset applied. To overcome this limitation, de Been et al. 9 developed a core-genome MLST (cgMLST) scheme for E. faecium based on 1423 target genes.
The aim of the study was to describe the occurrence of the vanA and vanB gene clusters among clinical E. faecium and E. faecalis in Denmark from 2005 to 2015 and to apply MLST and cgMLST to infer the genetic relatedness of E. faecium to understand the huge increase in vanA E. faecium in Denmark.
Materials and methods
National surveillance of vancomycin-resistant E. faecium and E. faecalis In 2015, 371 clinical VRE isolates from blood (n"30), urine (n"250) and other infection sites (n"91) originating from 10 of 11 DCMs (representing 95% of the Danish population) were whole-genome sequenced.
WGS and assembly
Of the 371 VRE isolates from 2015, 313 isolates were whole-genome sequenced at SSI, whereas 58 isolates from hospitals belonging to the clinical department at Hvidovre Hospital were whole-genome sequenced at their local facility.
Genomic DNA was extracted using a DNeasy Blood & Tissue Kit (QIAGEN, Copenhagen, Denmark) and fragment libraries were constructed using the Nextera Kit (Illumina, Little Chesterford, UK) followed by 251 bp paired-end sequencing at the SSI (MiSeq; Illumina) or 150 bp paired-end sequencing at Hvidovre Hospital (MiSeq; Illumina) according to the manufacturer's instructions. WGS data were assembled using CLCbio's Genomics Workbench v8.0 (QIAGEN, Aarhus, Denmark) using default settings to include only contigs .500 bp.
The ResFinder web server (http://www.genomicepidemiology.org) was used to identify van genes in the assembled genome data, using a threshold of 90% minimum sequence identity and 60% minimum length identity cut-off.
MLST was inferred from the WGS using the MLST web server (Version 1.7; http://www.genomicepidemiology.org).
The implementation of the cgMLST scheme by de Been et al. 9 in SeqSphere! v3.4.0 (Ridom GmbH, Münster, Germany; http://www.ridom. de/seqsphere/) was used for further subtyping of the vancomycin-resistant E. faecium isolates from 2015. New cluster types (CTs) identified as part of this study were submitted to the cgMLST database through the SeqSphere! v3.4.0 software suite.
Results and discussion

VRE prevalence over time in the Danish regions
During 2005-15, 1043 vanA E. faecium, 25 vanB E. faecium, 4 vanA E. faecalis and 28 vanB E. faecalis were detected at Danish hospitals and submitted to the SSI (Figure 1a ). Until 2012, the number of VRE isolated from clinical samples was ,50/year, but this number rapidly increased hereafter (Figure 1a 
Epidemiology during 2005-14
Subsets of the vancomycin-resistant E. faecium isolates from 2005 to 2014 have been characterized in previous studies. 4, 8, 11, 12 During 2005-09, a small outbreak of ST203 vanB E. faecium and two ST18 vanA E. faecium outbreaks were detected in the Capital Region.
11
From 2009 to 2013, vanA E. faecium increased at Aarhus University Hospital; the spread was due to multiple hospital outbreaks, including E. faecium isolates belonging to ST18, ST117, ST192, ST203 and ST260 (Table 1) . 12 Pinholt et al. 4 investigated vanA E. faecium isolates from the Danish hospitals from January 2012 to April 2013. The spread of several vanA clones was detected both within and between hospitals. The vanA E. faecium clones most often belonged to ST80, ST117 and ST192 (Table 1) . 4 The increase in vancomycin-resistant E. faecium in the Capital Region during 2012-14 was further studied by Pinholt et al. 8 SNP-based analysis of the WGS data divided the vanA E. faecium isolates into 13 main clades, 7 small clades and 13 singletons. Most of the isolates belonged to ST80, ST117 and ST192 (Table 1) .
WGS analysis of VRE from 2015
In the present study, all 369 Danish clinical vancomycinresistant E. faecium and the two clinical vancomycin-resistant E. faecalis isolates from 2015 were whole-genome sequenced. Both of the E. faecalis isolates belonged to ST6, one was vanA and the other vanB positive, and they were not investigated further. Of the E. faecium isolates, 368 were vanA positive and 1 carried the vanB gene. The majority (89%) of the vanA E. faecium isolates were from hospitals located on the Zealand island (the Capital Region and the Zealand Region) (Figure 1b) . The vast majority of the E. faecium isolates belonged to three STs; ST203 (51%), ST80 (33%, including the vanB isolate) and ST117 (10%) ( Table 2 ). The remaining isolates belonged to ST18, ST192 and the novel STs ST1196-ST1201, while one isolate (VRE2011) was non-typeable by MLST, due to a truncated VRE in Denmark, 2005-15 JAC purK gene. Recently, Carter et al. 13 reported on an outbreak with MLST non-typeable vancomycin-resistant E. faecium isolates from Australia; however, these were due to a truncated pstS gene.
cgMLST analysis
Using the cgMLST scheme with the suggested threshold of 20 alleles difference published by de Been et al., 9 the 368 vanA E. faecium isolates subdivided into 33 CTs (Table 2 and Figure 2 ). Hammerum et al.
In total, 187 (99%) of the 188 ST203 E. faecium isolates belonged to a new CT, which was designated CT859 upon submission to the cgMLST server through the SeqSphere! software, whereas a single ST203 isolate belonged to CT20. ST203-CT20 vanA E. faecium isolates have previously been detected in the Capital Region in Denmark in 2013 and 2014, corresponding to Group 8b in the publication by Pinholt et al. 8 Clinical E. faecium isolates belonging to ST203-CT20 have also been reported from Germany from 2013 to 2016 (http://www.cgMLST.org). In 2015, vanA E. faecium isolates belonging to ST203-CT859 could be detected in all five Danish regions, but the majority were detected in the Capital Region (n"137; 73%) and the Zealand Region (n"45; 24%). During 2015, ST203-CT859 vanA E. faecium were also detected from the Faroe Islands and from the southern part of Sweden. The presence was most likely due to patient transfer, as patients with ST203-CT859 vanA E. faecium had been transferred from hospitals in the Capital Region to the Faroe Islands and to Sweden on multiple occasions (Shahin Gaini, National Hospital Faroe Islands, personal communication; Petra Edquist, Public Health Agency of Sweden, personal communication). Four vanA E. faecium isolates constituting Group 8c in the paper by Pinholt et al. 8 all belonged to ST203-CT859 and were first detected during December 2014, but subsequently detected in clinical samples at three different hospitals within 12 days (Mette Pinholt, Hvidovre University Hospital, Denmark, personal communication). In total, 51% (187 of 368) of the Danish vanA E. faecium from 2015 belonged to the new CT859 variant, which has not been reported in the cgMLST database outside Denmark (accessed 25 January 2017). Arguably, the lack of non-Danish ST203-CT859 isolates in the cgMLST database could partly be explained by the fact that this database is relatively new and relies on availability of WGS data, which may currently be obstructive for some laboratories. Therefore, it may not reflect the true global diversity of E. faecium variants, which could mean that this variant may be present outside Denmark, Sweden and the Faroe Islands, but until more data are made available, we have no evidence to support this hypothesis. In conclusion, the apparent rapid emergence in Denmark remains an enigma and studies are currently ongoing to investigate the national epidemiology of this specific CT.
The 122 vanA E. faecium isolates belonging to ST80 were subdivided into two already known CTs (CT14 and CT16), as well as nine new CTs (860, 866-869, 871, 878, 881 and 992). The vanB isolate belonged to a separate CT (CT880). Eighty-two of the 122 ST80 vanA isolates belonged to CT14, which was detected in all five Danish regions. vanA E. faecium isolates belonging to ST80-CT14 were also detected in the Capital Region in 2013 (http://www. cgMLST.org), but the cgMLST database did not contain any nonDanish ST80-CT14 isolates. 9 Two vanA E. faecium isolates from the Capital Region belonged to ST80-CT16; this type has previously been detected in Denmark in 2012, as well as in Germany between 2013 and 2015 (http://www.cgMLST.org).
The 38 E. faecium isolates belonging to ST117 were subdivided into CT24 (n"23; 61%) and nine new CTs (861, 862, 872-875, 877, 882 and 883) by cgMLST. CT24 were detected from hospitals in the Zealand Region, the Capital Region and the Central Denmark Region (Figure 1b) . Isolates belonging to CT24 were also detected in 2010 in Danish hospitals as was observed when comparing WGS data from the ST117 E. faecium isolates from Aarhus University Hospital in the Central Denmark Region. 12 Furthermore, E. faecium isolates belonging to ST117-CT24 have been reported from clinical samples from Sweden in 2014 and Germany in 2014 and 2015 (http://www.cgMLST.org).
Six vanA E. faecium belonged to ST192. Three of these belonged to CT15, which previously has been detected in the Capital Region in June 2013 (http://www.cgMLST.org). 9 One of the ST192 vanA E. faecium isolates belonged to CT46, which has also been reported from Germany in 2014 and 2015; http://www.cgMLST.org). The remaining ST192 vanA E. faecium isolates belonged to CT865, a new CT. The five ST18 vanA E. faecium isolates belonged to five different cgMLST CTs (CT863, CT864, CT870, CT876 and CT884) and were therefore not considered clonally related. Eight of the vanA E. faecium isolates belonged to new STs (ST1196-ST1201). ST1196-ST1198 were single-locus variants of ST80; the three isolates belonging to these new STs sub-clustered to already known (6) CT15 (3), CT46 (1), CT865 (2) ST203 (188) CT20 (1), CT859 (187) ST1196 (1) CT866 (1) ST1197 (1) CT871 (1) ST1198 (1) CT14 (1) ST1199 (1) CT885 (1) ST1200 (3) CT877 (2), CT879 (1) ST1201 (1) CT24 (1) Non-typeable (1) CT860 ( Hammerum et al.
CTs (CT14, CT866 and CT871) together with other isolates belonging to ST80. The isolate belonging to ST1199, a single-locus variant of ST117, belonged to a new CT, CT885. The three isolates belonging to ST1200, another single-locus variant of ST117, were subdivided into CT877 (n"2) and a new CT, CT879 (n"1). The isolate belonging to ST1201, a third single-locus variant of ST117, belonged to CT24 similar to other ST117 isolates. Our data highlight the usefulness of cgMLST for sub-clustering of isolates beyond conventional MLST and, in combination with future records in the cgMLST scheme, will produce a powerful tool for the detection of emerging clones and outbreaks across regional and national borders.
Increased use of antimicrobial agents
In the last decade, vanA E. faecium isolates submitted from Danish DCMs have increased rapidly. The significant increase in vanA E. faecium between 2012 and 2015 is highly regional and linked to the Capital Region and the Zealand Region and follows a similar regional increase in nosocomial Clostridium difficile CD027 infections.
14 As C. difficile infections are often treated with vancomycin, a result of this could be a stronger selection for VRE at the hospitals in these regions. 15 Isaac et al. 16 recently showed that the human intestinal microbiota can change drastically during oral vancomycin treatment. The clinical relevance of the observed microbiota changes were further demonstrated in mice, which developed analogous microbiota alterations. During vancomycin treatment, mice were highly susceptible to intestinal colonization by a vancomycin-resistant E. faecium strain. 16 Furthermore, in the last 20 years the use of cephalosporins has increased in Danish hospitals. 15, 17 Similar to the mice study with vancomycin, mice treated with cefuroxime were also colonized with a CC17 ampicillinresistant E. faecium isolate. 18 So the increased use of cephalosporins might have contributed to an increase in the number of infections caused by E. faecium and stresses the fact that a rational antibiotic prescription pattern is an important prevention measure.
VRE can be carried in the intestine for a long period without any symptoms of infection and likewise persist in the hospital environment. This challenges infection control measures consisting of cleaning and hand hygiene, as well as screening for VRE and isolation of patients.
Conclusions
During 2005-15 vanA E. faecium increased dramatically in Denmark. In the period 2009-13, several vanA E. faecium outbreaks were detected in the Central Denmark Region. Since 2013 vanA E. faecium has become endemic in the Capital Region and the Zealand Region. In 2015, a new type, ST203-CT859, emerged and spread across Danish borders. Further studies are ongoing to investigate the cause of the spreading capacity of ST203-CT859 E. faecium. Besides ST203-CT859 E. faecium, E. faecium belonging to several other CTs were detected; many of these have been detected before, both inside and outside of Denmark.
